130 related articles for article (PubMed ID: 2040009)
1. Elimination of V beta 2 bearing T-cells in BALB/c mice implanted with syngeneic preneoplastic and neoplastic mammary lesions.
Wei WZ; Ficsor-Jacobs R; Tsai SJ; Pauley R
Cancer Res; 1991 Jun; 51(12):3331-3. PubMed ID: 2040009
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfer of V beta 2-deleting activity with host cells from mice implanted with C4 preneoplastic hyperplastic alveolar nodules.
Wei WZ; Wang H; Ficsor-Jacobs R; Pauley R
Cancer Res; 1992 Oct; 52(19):5183-9. PubMed ID: 1327503
[TBL] [Abstract][Full Text] [Related]
3. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
[TBL] [Abstract][Full Text] [Related]
4. Associated effects of bromocriptine on neoplastic progression of mouse mammary preneoplastic hyperplastic alveolar nodule line C4 and on hyperplastic alveolar nodule-infiltrating and splenic lymphocyte function.
Tsai SJ; Loeffler DA; Heppner GH
Cancer Res; 1992 Apr; 52(8):2209-15. PubMed ID: 1559224
[TBL] [Abstract][Full Text] [Related]
5. Microcytotoxicity assay of immune responses to non-mammary tumor virus-induced, preneoplastic, and neoplastic mammary lesions in BALB/c mice.
Heppner GH; Kopp JS; Medina D
Cancer Res; 1976 Feb; 36(2 pt 2):753-8. PubMed ID: 1253160
[TBL] [Abstract][Full Text] [Related]
6. Characterization of lymphocytic infiltrates in normal, preneoplastic, and neoplastic mouse mammary tissues.
Wei WZ; Malone K; Mahoney K; Heppner G
Cancer Res; 1986 Jun; 46(6):2680-5. PubMed ID: 3084071
[TBL] [Abstract][Full Text] [Related]
7. Deletion of CD4+ T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4)-infected V beta 2 transgenic mice.
Wang H; Gill RF; Lichlyter D; Iglesias A; Bluethmann H; Wei WZ
Eur J Immunol; 1994 Dec; 24(12):2950-6. PubMed ID: 7805721
[TBL] [Abstract][Full Text] [Related]
8. Correlation of natural killer activity with tumorigenesis of a preneoplastic mouse mammary lesion.
Wei WZ; Fulton A; Winkelhake J; Heppner G
Cancer Res; 1989 May; 49(10):2709-15. PubMed ID: 2785436
[TBL] [Abstract][Full Text] [Related]
9. Detection of inapparent nodule-transformed cells in the mammary gland tissues of virgin female BALB/cfC3H mice.
DeOme KB; Miyamoto MJ; Osborn RC; Guzman RC; Lum K
Cancer Res; 1978 Jul; 38(7):2103-11. PubMed ID: 207423
[TBL] [Abstract][Full Text] [Related]
10. A kinetic study on the deletion of thymic, peripheral, and gut-associated V beta 6+ T cells in an Mls-1b BALB/c colony infected with an exogenous mouse mammary tumor virus.
Tucek CL; Desaymard C; Papiernik M
J Immunol; 1993 Jul; 151(2):759-66. PubMed ID: 8101538
[TBL] [Abstract][Full Text] [Related]
11. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
12. Dominant V beta 8 gene usage in response to TNP: failure to use other V beta chains following removal of V beta 8+ T cells by monoclonal antibody in vivo.
Dieli F; Asherson GL; Sireci G; Tantillo G; del Carpio C; Salerno A
Immunology; 1994 May; 82(1):99-105. PubMed ID: 8045598
[TBL] [Abstract][Full Text] [Related]
13. A new infectious mammary tumor virus in the milk of mice implanted with C4 hyperplastic alveolar nodules.
Shakhov AN; Wang H; Acha-Orbea H; Pauley RJ; Wei WZ
Eur J Immunol; 1993 Nov; 23(11):2765-9. PubMed ID: 8223852
[TBL] [Abstract][Full Text] [Related]
14. In vivo elimination of T cells expressing specific T-cell receptor V beta chains in mice susceptible to collagen-induced arthritis.
Goldschmidt TJ; Jansson L; Holmdahl R
Immunology; 1990 Apr; 69(4):508-14. PubMed ID: 2139866
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of keratin expression in mouse mammary hyperplastic alveolar nodules and adenocarcinomas.
Asch HL; Asch BB
Cancer Res; 1985 Jun; 45(6):2760-8. PubMed ID: 2580627
[TBL] [Abstract][Full Text] [Related]
16. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis (MAM). VIII. Selective activation of T cells expressing distinct V beta T cell receptors from various strains of mice by the "superantigen" MAM.
Cole BC; Kartchner DR; Wells DJ
J Immunol; 1990 Jan; 144(2):425-31. PubMed ID: 2136890
[TBL] [Abstract][Full Text] [Related]
18. The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy.
Katz JD; Lebow LT; Bonavida B
J Immunol; 1989 Aug; 143(4):1387-95. PubMed ID: 2663994
[TBL] [Abstract][Full Text] [Related]
19. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
[TBL] [Abstract][Full Text] [Related]
20. Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor. Activation-induced cell death vs passive macrophage-dependent deletion.
Gonzalo JA; Baixeras E; González-García A; George-Chandy A; Van Rooijen N; Martínez C; Kroemer G
J Immunol; 1994 Feb; 152(4):1597-608. PubMed ID: 8120373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
